Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1342 studies found for:    Open Studies | "Lung Neoplasms"
Show Display Options
Rank Status Study
1 Unknown  Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours
Conditions: Lung Neoplasms;   Lung Cancer
Intervention: Procedure: Fractionated Stereotactic Radiotherapy
2 Unknown  Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Dysgeusia;   Taste Disorders;   Lung Neoplasms;   Small Cell Lung Carcinoma
Intervention:
3 Not yet recruiting Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma
Conditions: Lung Cancer;   Squamous Cell Carcinoma of the Lung;   Locally Advanced and Metastatic Squamous Cell Carcinoma of the Lung
Interventions: Drug: Intravenous Cisplatin & etoposide;   Drug: Intravenous Cisplatin & etoposide along with oral cyclophosphamide
4 Recruiting Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Conditions: Small Cell Lung Carcinoma;   Non Small Cell Lung Carcinoma;   Irinotecan Sensitive Cancers
Interventions: Drug: Carfilzomib;   Drug: Irinotecan
5 Recruiting Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery
Conditions: Stage IA Non-Small Cell Lung Carcinoma;   Stage IB Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Azacitidine;   Drug: Entinostat;   Procedure: Therapeutic Conventional Surgery;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
6 Recruiting TF2- Small Cell Lung Cancer Radio Immunotherapy
Conditions: Small Cell Lung Cancer;   CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)
Interventions: Drug: Antibody TF2;   Radiation: IMP-288-Lutetium;   Radiation: IMP-288-Indium
7 Recruiting Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic;   Small Cell Lung Carcinoma
Intervention: Other: therapeutic interventions
8 Not yet recruiting A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
Condition: Carcinoma of the Lung.
Interventions: Drug: Binimetinib;   Drug: Pemetrexed;   Drug: Carboplatin
9 Recruiting Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
Condition: Lung Neoplasms
Intervention:
10 Recruiting Biomarkers for Diagnosis of Lung Cancer
Conditions: Lung Cancer;   Lung Neoplasm
Intervention:
11 Recruiting Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer
Conditions: Adenosquamous Lung Carcinoma;   Bronchioloalveolar Carcinoma;   Large Cell Lung Carcinoma;   Lung Adenocarcinoma;   Squamous Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Radiation: External Beam Radiation Therapy;   Radiation: Image-Guided Adaptive Radiation Therapy;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
12 Not yet recruiting Role of Bronchoscopy in Early Lung Cancer Screening of High Risk Population
Condition: Lung Neoplasms
Intervention: Procedure: Fluorescence Bronchoscopy/Narrow Band Bronchoscopy
13 Recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Conditions: Adenosquamous Lung Carcinoma;   Bronchioloalveolar Carcinoma;   Large Cell Lung Carcinoma;   Lung Adenocarcinoma;   Squamous Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Drug: Veliparib;   Other: Hydrocortisone/Placebo;   Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: 3-Dimensional Conformal Radiation Therapy
14 Unknown  Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Lung Neoplasms
Interventions: Drug: Treated by endostar combined with docetaxel and cisplatin;   Drug: Treated by docetaxel and cisplatin
15 Recruiting Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-Small Cell Lung Cancer
Conditions: Carcinoma of Unknown Primary Origin;   Extensive Stage Small Cell Lung Carcinoma;   Large Cell Lung Carcinoma;   Neuroendocrine Carcinoma;   Newly Diagnosed Carcinoma of Unknown Primary Origin;   Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Veliparib;   Other: Placebo;   Drug: Etoposide;   Drug: Cisplatin;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment
16 Unknown  Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases
Conditions: Lung Neoplasms;   Neoplasm Metastasis
Intervention: Drug: Cisplatin, Thiosulfate
17 Recruiting Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China
Condition: Lung Neoplasms
Intervention:
18 Recruiting Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IB Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Erlotinib Hydrochloride;   Other: Placebo;   Other: Laboratory Biomarker Analysis
19 Not yet recruiting Virtual Intervention for Lung Cancer
Condition: Lung Neoplasms
Interventions: Behavioral: Virtual experience;   Behavioral: Videos
20 Recruiting Correlation Research of Thioredoxin Reductase in Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Benign Neoplasm of Lung
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years